AstraZeneca

The Australian Greens have called on the federal government to increase the production of COVID-19 vaccines. The party recently welcomed the news that AstraZeneca has been approved by the Therapeutic Goods Administration for use in Australia. Australian Greens spokesperson on Health, Senator Rachel Siewart, said Australia needs to build a diverse portfolio of vaccines in … Continue reading Diverse COVID-19 vaccine portfolio needed, says Australian Greens →

Global biopharmaceuticals manufacturer AstraZeneca has committed $200 million to the company’s facility in North Ryde, Sydney. The investment will go towards increasing the facility’s production capabilities, creating 250 jobs and increasing exports to $4.4 billion over the next four years. The investment is in addition to the $100 million announced in 2017. Chief executive officer, … Continue reading AstraZeneca invests $200m in local manufacturing capability →

While conditions in the Australian manufacturing industry remain challenging amid weakness in the global economy, there are certain companies that are bucking the trend and taking advantage of strong opportunities for growth.

Australia’s car industry is faltering and our wine sector is facing increasing offshore competition, however, there is good news when it comes to pharmaceutical manufacturers, Alex Heber reports.